Luxna Biotech Co., Ltd.
PrivateLast Round
Series C
Extension
Aug 7, 2025
Total Funding Raised
$12.43M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Luxna Biotech Co., Ltd. is a biotechnology company that develops oligonucleotide therapeutics based on modified nucleic acid technology licensed from Osaka University.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Luxna Biotech Co., Ltd. Comparables
Compare Luxna Biotech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SynGenis | 78% | |
| ChemGenes Corporation | 76% | |
| Hongene Biotechnology | 76% | |
Luxna Biotech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Aug 7, 2025 | ||||
| Series C | Sep 6, 2024 | ||||
| Debt | Dec 16, 2021 | ||||
| Series A | Feb 10, 2020 | ||||
| Debt | Nov 1, 2019 | ||||
Seed | Mar 1, 2018 |
Luxna Biotech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kobe University Capital | Series C Extension |
| Shinsei Capital Partners | Debt |
| Mizuho Capital | Debt, Series A |
| 株式会社日本政策金融公庫 | Debt |
| Tohoku University Venture Partners | Series C |
| DCI Partners | Series C |
| 日本ベンチャーキャピタル株式会社 | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors increased 156% MoM, reaching 4.3K.
- Mar 16, 2026
Partnered with Inabata to expand GuNA amidite supply.
Luxna Biotech Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Luxna Biotech Co., Ltd.'s valuation, stock price, and market status.